.
.
.
.

Possible link between COVID-19 vaccine and deep vein blood clots: EU regulator

Published: Updated:

The European Union’s drug regulator said on Friday there is a possible link between rare cases of bloods clots in deep veins with Johnson & Johnson’s COVID-19 vaccine and recommended the condition be listed as a side-effect of the shot.

For the latest headlines, follow our Google News channel online or via the app.

The European Medicines Agency also recommended immune thrombocytopenia (ITP), a bleeding disorder caused by the body mistakenly attacking platelets, be added as an adverse reaction with an unknown frequency to the J&J vaccine product information and to AstraZeneca’s vaccine.

Read more:

Surgical patients who had COVID-19 more likely to develop fatal blood clots: Study

Blood clot risk much higher from COVID-19 than with vaccines: UK study

J&J says COVID-19 booster dose increased antibodies in early-stage trials